27Mar

HORIBA Medical launches D-Dimer reagent for Yumizen G Haemostasis range

Horibalogo

Northampton, UK – 21 March 2019 – HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G haemostasis range of instruments. The new Yumizen G DDi 2 (D-Dimer) reagent kit offers a key measurement and reference exclusion test for the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be used for monitoring the progress and effectiveness of treatment of Disseminated Intravascular Coagulation (DIC).

HORIBA Medical’s new D-Dimer reagent kit is available for its full range of coagulation instruments which covers the needs of any laboratory. The dedicated haemostasis portfolio includes the fully automatic Yumizen G800, Yumizen G1500 and Yumizen G1550, as well as semi-automatic Yumizen G200 and Yumizen G400 analysers. Using antibody-coated latex particles and measured via the immuno-turbidimetric channels of these Yumizen G instruments, the new reagent kit delivers D-Dimer results consistency across the range.

The D-Dimer assay when used on very compact coagulation screening platforms such as the Yumizen G400DDi and Yumizen G200, which also have combined immuno-turbidimetric and chromogenic assay capabilities, is particularly ideal for small laboratories, hot labs and as backup. On these semi-automatic systems, the Yumizen G DDi 2 reagent kit offers an innovative combination of immuno-turbidimetric test capability and pre-calibrated ready-to-use reagent.

Offering a cost-efficient solution, the new assay minimises preparation time due to its ready-to-use liquid format. Furthermore, as the reagent is pre-calibrated it removes the need for a costly and time-consuming calibration step. Its high stability and optimised volume packaging also avoids wastage.

HORIBA Medical’s new D-Dimer test kit is fully compliant with Gold Standard performances, having a Negative Predictive Value of 99% and an absence of hook effect up to 25 µg FEU/ml. It also offers slope check and post dilution function on both fully automatic and semi-automatic systems with a cut-off value at 0.5 µg FEU/ml.

For more information on HORIBA UK Ltd. Medical and its products, including its new Yumizen GDDi 2 (D-Dimer) kit and Yumizen G haemostasis range of analysers, please visit: www.horiba.com/uk/medical.

Related

Abingdon Health and DCN Diagnostics partner on commercialisation of AppDx m-Health technology

Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Heal...

Read More >

Biofortuna closes £1.6M funding round

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract m...

Read More >

EKF signs DiaSpect Tm U.S. distribution agreement with McKesson to launch McKesson Consult® Hb analyzer

FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most esta...

Read More >

OGT unveils reliable somatic CNV detection for CLL with new NGS panel

SureSeq™ CLL + CNV - comprehensive CLL genomic profiling from a single assay

Read More >

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and c...

Read More >

RPS Diagnostics partners with Atomo Diagnostics to develop next generation Febridx blood tests for Antibiotic Stewardship in the Outpatient setting

Sarasota, Florida and Sydney, Australia (February 20, 2018) – United States biotechnology company, ...

Read More >